Cargando…

Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations

In Europe, National Immunisation Technical Advisory Groups (NITAGs) were established in most countries to promote evidence-informed decision-making in introducing new or improved vaccines or changing recommendations for existing ones. Still, the role, activities and outcomes of NITAGs have not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinelli, Domenico, Quattrone, Filippo, Fortunato, Francesca, Di Maggio, Elisa, Filia, Antonietta, Rota, Maria Cristina, Lopalco, Pier Luigi, Prato, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604541/
https://www.ncbi.nlm.nih.gov/pubmed/37883041
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.43.2300131
_version_ 1785126859606851584
author Martinelli, Domenico
Quattrone, Filippo
Fortunato, Francesca
Di Maggio, Elisa
Filia, Antonietta
Rota, Maria Cristina
Lopalco, Pier Luigi
Prato, Rosa
author_facet Martinelli, Domenico
Quattrone, Filippo
Fortunato, Francesca
Di Maggio, Elisa
Filia, Antonietta
Rota, Maria Cristina
Lopalco, Pier Luigi
Prato, Rosa
author_sort Martinelli, Domenico
collection PubMed
description In Europe, National Immunisation Technical Advisory Groups (NITAGs) were established in most countries to promote evidence-informed decision-making in introducing new or improved vaccines or changing recommendations for existing ones. Still, the role, activities and outcomes of NITAGs have not been optimally implemented across Europe. Within the European Joint Action on Vaccination (EU-JAV), we conducted a survey to collect information on decision-making process including the main criteria for the introduction of new vaccines or changes to recommendations on their use. Between December 2021 and January 2022, 13 of the 28 European countries invited participated in an online survey. The criteria ranked as most relevant were disease burden and availability of financial resources. Only one country specified that the NITAG recommendations were binding for the government or the health authority. Vaccinations more often reported for introduction or recommendation changes were those against herpes zoster, influenza, human papillomavirus infection, pneumococcal and meningococcal disease. The planned changes will mainly address children and adolescents (2–18 years) and adults (≥ 45–65 years). Our findings show potential overlaps in the activities of NITAGs between countries; and therefore, collaboration between NITAGs may lead to optimisation of the workload and better use of resources.
format Online
Article
Text
id pubmed-10604541
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-106045412023-10-28 Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations Martinelli, Domenico Quattrone, Filippo Fortunato, Francesca Di Maggio, Elisa Filia, Antonietta Rota, Maria Cristina Lopalco, Pier Luigi Prato, Rosa Euro Surveill Perspective In Europe, National Immunisation Technical Advisory Groups (NITAGs) were established in most countries to promote evidence-informed decision-making in introducing new or improved vaccines or changing recommendations for existing ones. Still, the role, activities and outcomes of NITAGs have not been optimally implemented across Europe. Within the European Joint Action on Vaccination (EU-JAV), we conducted a survey to collect information on decision-making process including the main criteria for the introduction of new vaccines or changes to recommendations on their use. Between December 2021 and January 2022, 13 of the 28 European countries invited participated in an online survey. The criteria ranked as most relevant were disease burden and availability of financial resources. Only one country specified that the NITAG recommendations were binding for the government or the health authority. Vaccinations more often reported for introduction or recommendation changes were those against herpes zoster, influenza, human papillomavirus infection, pneumococcal and meningococcal disease. The planned changes will mainly address children and adolescents (2–18 years) and adults (≥ 45–65 years). Our findings show potential overlaps in the activities of NITAGs between countries; and therefore, collaboration between NITAGs may lead to optimisation of the workload and better use of resources. European Centre for Disease Prevention and Control (ECDC) 2023-10-26 /pmc/articles/PMC10604541/ /pubmed/37883041 http://dx.doi.org/10.2807/1560-7917.ES.2023.28.43.2300131 Text en This article is copyright of the authors or their affiliated institutions, 2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Perspective
Martinelli, Domenico
Quattrone, Filippo
Fortunato, Francesca
Di Maggio, Elisa
Filia, Antonietta
Rota, Maria Cristina
Lopalco, Pier Luigi
Prato, Rosa
Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations
title Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations
title_full Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations
title_fullStr Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations
title_full_unstemmed Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations
title_short Role of the National Immunisation Technical Advisory Groups in 13 European countries in the decision-making process on vaccine recommendations
title_sort role of the national immunisation technical advisory groups in 13 european countries in the decision-making process on vaccine recommendations
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604541/
https://www.ncbi.nlm.nih.gov/pubmed/37883041
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.43.2300131
work_keys_str_mv AT martinellidomenico roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations
AT quattronefilippo roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations
AT fortunatofrancesca roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations
AT dimaggioelisa roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations
AT filiaantonietta roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations
AT rotamariacristina roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations
AT lopalcopierluigi roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations
AT pratorosa roleofthenationalimmunisationtechnicaladvisorygroupsin13europeancountriesinthedecisionmakingprocessonvaccinerecommendations